In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Tuesday, Sept. 8, 2020, the top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus said that they will stick to the highest ethical and scientific standards in testing and manufacturing and will make the well-being of those getting vaccinated their top priority. (AP Photo/Hans Pennink)
By Linda A. Johnson
The top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus signed an unprecedented pledge meant to boost public confidence in any approved vaccines.
The companies said Tuesday that they will stick to the highest ethical and scientific standards in testing and manufacturing and will make the well-being of those getting vaccinated their top priority.
The announcement comes amid worries that the U.S. Food and Drug Administration will be under political pressure to approve a vaccine before tests to prove it is safe and effective are finished.
Meanwhile, public health officials worry that if many Americans don't get the vaccine, it will be harder to reduce the spread of COVID-19.
The pledge was signed by the chief executive officers of American drugmakers Johnson & Johnson, Merck, Moderna, Novavax, and Pfizer, and European companies AstraZeneca, BioNTech, GlaxoSmithKline, and Sanofi. BioNTech has partnered with Pfizer on one of the vaccines now in the final round of human testing.
Veetahl Eilat-Raichel, Founder and CEO of Sorbet, shares how employees can harness the value of their time off – and how companies can use PTO to employees’ benefit.
Brooke May, Managing Partner at Evans May Wealth, weighs in on how the market is expected to perform through the rest of 2024, plus why she’s still bullish on tech but cautious when it comes to financials.
Pete Nicoletti, Global CISO at Check Point, explains why it’s so difficult to legislate against A.I. disinformation and why it’s a concern going into the 2024 election.
Michelle Freyre, Clinique Global Brand President, discusses the company's latest ventures and why skin advice should always come from a trusted source.
Jason Tartick, small business expert and TurboTax Live Partner (who you may recognize from 'The Bachelorette'), shares his tips for making sure your taxes are flawless this year.
Christine Short, Head of Research, Global Corporate Events at Wall Street Horizon, a TMX Company, breaks down the biggest takeaways from companies’ quarterly results.
